| Outcome Measures: |
Primary: Change in Glycated haemoglobin (HbA1c ), Percent-points, From baseline (week 0) to End of Study visit (V3) (week 34-44) | Secondary: Relative change in body weight, Percent, From baseline (week 0) to End of Study visit (V3) (week 34-44)|Absolute change in body weight, Kilogram (Kg), From baseline (week 0) to End of Study visit (V3) (week 34-44)|HbA1c <7% (Yes/No), Percentage of patients achieving or not achieving the target value, End of Study visit (V3) (week 34-44)|HbA1c reduction >=1%-points and body weight reduction of >=5% (Yes/No), Percentage of patients achieving or not achieving the reduction, From baseline (week 0) to End of Study visit (V3) (week 34-44)|HbA1c reduction >=1%-points and body weight reduction of >=3% (Yes/No), Percentage of patients achieving or not achieving the reduction, From baseline (week 0) to End of Study visit (V3) (week 34-44)|Diabetes Treatment Satisfaction Questionnaire, change (DTSQc), relative treatment satisfaction, Total score, End of Study visit (V3) (week 34-44)|Diabetes Treatment Satisfaction Questionnaire, status (DTSQs), change in absolute treatment satisfaction, Total score, From baseline (week 0) to End of Study visit (V3) (week 34-44)
|
